In 2024, the cold agglutinin disease treatment market stood at USD 95.94 million and is projected to surge at a CAGR of 23.60% from 2025 to 2034, hitting USD 798.33 million by the end of the period. This sharp rise is due to increasing awareness, improved diagnostics, and better healthcare infrastructure in key regions. https://www.expertmarketresearch.com/reports/cold-agglutinin-disease-treatment-market